Lataa...
Modern insulins, old paradigms and pragmatism: choosing wisely when deciding how to treat type 1 diabetes
There is a clinical imperative to improve metabolic control in the treatment of patients with type 1 diabetes, but in doing so, hypoglycemia should be avoided at all costs. Insulin analogues and the assumption they would better mimic the pharmacokinetic profile of endogenous insulin secretion emerge...
Tallennettuna:
| Julkaisussa: | Diabetol Metab Syndr |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4426553/ https://ncbi.nlm.nih.gov/pubmed/25964802 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13098-015-0033-4 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|